| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSL1600048 | 重组人源化抗人白介素6受体单克隆抗体注射液 | Injection | Biological Products(2) | New Drug Application | 2016-07-15 | 百奥泰生物科技（广州）有限公司 | Bio-Thera Solutions Ltd | Certificate Issued | 2017-11-21 | view | |
| CXSL1600124 | 重组人源化抗人白介素6受体单克隆抗体注射液 | Injection | Biological Products(2) | New Drug Application | 2017-02-13 | 百奥泰生物科技（广州）有限公司 | Bio-Thera Solutions Ltd | Certificate Issued | 2017-05-22 | view | |
| CXSL1700167 | 重组人源化抗白介素-6受体单克隆抗体注射液 | Injection | Biological Products(1) | New Drug Application | 2018-03-28 | 北京伟德杰生物科技有限公司 | BeiJing VDJBio Co Ltd | In Review | 2018-03-27 | view | |
| CXSL2101184 | 重组人源化抗白介素-6受体单克隆抗体注射液 | Injection | Biological Products(1) | New Drug Application | 2021-07-14 | BeiJing VDJBio Co Ltd | view | ||||
| CXSB2400032 | 重组人源化抗白介素-6受体单克隆抗体注射液 | Injection | Biological Products(1) | Supplementary Application | 2024-04-11 | view |